Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
A
Aarti Drugs Ltd
Score 68/100• Decent
Aarti Drugs Ltd shows potential for growth but faces several risks that could impact its performance.
Company’s Health73/100
Valuation 40/100 · PB 3.3923
Technical Avoid
1M -1.396% 6M 43.265% 1Y 0.742%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#121
View details ➜
A
Aatmaj Healthcare Ltd
Score 68/100• Decent
Aatmaj Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health83/100
Valuation 100/100 · PB 0.9469
Technical Avoid
1M 0% 6M 27.273% 1Y -20.152%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#122
View details ➜
Q
Quest Laboratories Ltd
Score 66/100• Decent
Quest Laboratories Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health90/100
Valuation 80/100 · PB 1.7627
Technical Avoid
1M -8.273% 6M -25.424% 1Y -14.811%
Confidence100%
Low leverage (D/E)No promoter pledge
#123
View details ➜
K
Krishna Institute of Medical Sciences Ltd
Score 66/100• Decent
The stock shows decent potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health82/100
Valuation 20/100 · PB 12.0341
Technical Avoid
1M -5.456% 6M 15.368% 1Y 30.029%
Confidence100%
No promoter pledgeHealthy profit margins
#124
View details ➜
M
MedPlus Health Services Ltd
Score 66/100• Decent
MedPlus Health Services Ltd shows potential for growth, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health52/100
Valuation 20/100 · PB 5.2092
Technical Avoid
1M -8.109% 6M -5.9% 1Y 11.205%
Confidence100%
Weak ROEPromoter pledge present
#125
View details ➜
Y
Yatharth Hospital & Trauma Care Services Ltd
Score 66/100• Decent
Yatharth Hospital shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health71/100
Valuation 40/100 · PB 4.7808
Technical Watch
1M 4.501% 6M 67.536% 1Y 28.896%
Confidence100%
Low leverage (D/E)Healthy profit margins
Weak ROEPromoter pledge present
#126
View details ➜
T
Torrent Pharmaceuticals Ltd
Score 66/100• Decent
Torrent Pharmaceuticals shows decent potential with a solid business model and growth prospects, but faces challenges in profitability and valuation metrics.
Company’s Health90/100
Valuation 20/100 · PB 15.7517
Technical Avoid
1M -1.755% 6M 9.653% 1Y 1.006%
Confidence100%
Low leverage (D/E)No promoter pledge
#127
View details ➜
J
Jeevan Scientific Technology Ltd
Score 66/100• Decent
Jeevan Scientific Technology Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health63/100
Valuation 80/100 · PB 1.9192
Technical Momentum
1M 57.989% 6M 46.206% 1Y 15.446%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#128
View details ➜
T
Titan Biotech Ltd
Score 66/100• Decent
Titan Biotech Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
Company’s Health92/100
Valuation 20/100 · PB 7.3145
Technical Momentum
1M 63.319% 6M 168.366% 1Y 59.067%
Confidence100%
Low leverage (D/E)No promoter pledge
#129
View details ➜
S
Star Imaging and Path Lab Ltd
Score 66/100• Decent
Star Imaging and Path Lab Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
Company’s Health97/100
Valuation 40/100 · PB 4.8317
Technical Avoid
1M -0.758% 6M -3.641% 1Y -3.641%
Confidence100%
No promoter pledgeHealthy profit margins
#130
View details ➜
S
Sanofi India Ltd
Score 66/100• Decent
Sanofi India Ltd shows a decent investment opportunity with a solid business model and growth potential, though some risks remain.
Company’s Health97/100
Valuation 20/100 · PB 12.5611
Technical Avoid
1M -6.983% 6M -24.092% 1Y -31.646%
Confidence100%
Low leverage (D/E)No promoter pledge
#131
View details ➜
P
Parmax Pharma Ltd
Score 66/100• Decent
Parmax Pharma Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health46/100
Valuation 100/100 · PB -6.4862
Technical Avoid
1M -9.143% 6M -20.231% 1Y -13.447%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#132
View details ➜
N
Nephro Care India Ltd
Score 66/100• Decent
Nephro Care India Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health83/100
Valuation 40/100 · PB 4.2225
Technical Avoid
1M -15.854% 6M -6.929% 1Y -44.98%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#133
View details ➜
A
Anthem Biosciences Ltd
Score 66/100• Decent
Anthem Biosciences Ltd shows potential but faces challenges in growth consistency and profitability metrics.
Company’s Health100/100
Valuation 20/100 · PB 18.0739
Technical Avoid
1M -7.007% 6M 6.189% 1Y 6.189%
Confidence100%
Low leverage (D/E)No promoter pledge
#134
View details ➜
H
Healthcare Global Enterprises Ltd
Score 66/100• Decent
Healthcare Global Enterprises Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
Company’s Health41/100
Valuation 20/100 · PB 9.7683
Technical Avoid
1M 2.032% 6M 19.36% 1Y 53.12%
Confidence100%
Decent revenue growth
Weak ROEHigh debt/equity
#135
View details ➜
Showing 121 to 135 of 301 (21 Pages)